Cowen Starts Celldex Therapeutics (CLDX) at Outperform
Tweet
Share
E-mailGet Alerts CLDX Hot Sheet
Price: $39.06 -0.15%
Rating Summary:
18 Buy, 3 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 9 | Down: 6 | New: 60
Rating Summary:
18 Buy, 3 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 9 | Down: 6 | New: 60
Join SI Premium – FREE
Cowen initiated coverage on Celldex Therapeutics (NASDAQ: CLDX) with an Outperform rating and a price target of $22.00.
For an analyst ratings summary and ratings history on Celldex Therapeutics click here. For more ratings news on Celldex Therapeutics click here.
Shares of Celldex Therapeutics closed at $14.16 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- TD Cowen Starts Faeth Therapeutics (FTH) at Buy
- Nomura/Instinet Starts Astra Agro Lestari Tbk PT (AALI:IJ) (AAGRY) at Buy
- Cantor Fitzgerald Starts Sagimet Biosciences Inc (SGMT) at Overweight
Create E-mail Alert Related Categories
New CoverageRelated Entities
Cowen & CoSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
